---
figid: PMC6598962__10495_2019_1542_Fig6_HTML
figtitle: Cooperation of 17-aminogeldanamycin (AG) and trametinib (TRA) or vemurafenib
  (PLX) a A schematic summary of molecular effects of TRA, and PLX activity, and 17-aminogeldanamycin-mediated
  HSP90 inhibition in melanoma cells
organisms:
- NA
pmcid: PMC6598962
filename: 10495_2019_1542_Fig6_HTML.jpg
figlink: /pmc/articles/PMC6598962/figure/Fig6/
number: F6
caption: Cooperation of 17-aminogeldanamycin (AG) and trametinib (TRA) or vemurafenib
  (PLX) a A schematic summary of molecular effects of TRA, and PLX activity, and 17-aminogeldanamycin-mediated
  HSP90 inhibition in melanoma cells. Alterations accompanying acute (4–6 h) and prolonged
  (22–24 h) response are shown. See discussion for additional comments. ERAD, endoplasmic
  reticulum-associated protein degradation b Transcript levels of XBP1 s, GRP78, HSP70
  and CHOP were determined by qRT-PCR in drug-naïve BRAFV600E and NRASQ61R melanoma
  cell lines, and expressed relatively to the median value in all five cell lines.
  *p ≤ 0.05 versus median value
papertitle: 17-Aminogeldanamycin selectively diminishes IRE1α-XBP1s pathway activity
  and cooperatively induces apoptosis with MEK1/2 and BRAFV600E inhibitors in melanoma
  cells of different genetic subtypes.
reftext: Aleksandra Mielczarek-Lewandowska, et al. Apoptosis. 2019;24(7):596-611.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.6667159
figid_alias: PMC6598962__F6
figtype: Figure
organisms_ner:
- Caenorhabditis elegans
- Homo sapiens
redirect_from: /figures/PMC6598962__F6
ndex: 8912d35f-de9f-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6598962__10495_2019_1542_Fig6_HTML.html
  '@type': Dataset
  description: Cooperation of 17-aminogeldanamycin (AG) and trametinib (TRA) or vemurafenib
    (PLX) a A schematic summary of molecular effects of TRA, and PLX activity, and
    17-aminogeldanamycin-mediated HSP90 inhibition in melanoma cells. Alterations
    accompanying acute (4–6 h) and prolonged (22–24 h) response are shown. See discussion
    for additional comments. ERAD, endoplasmic reticulum-associated protein degradation
    b Transcript levels of XBP1 s, GRP78, HSP70 and CHOP were determined by qRT-PCR
    in drug-naïve BRAFV600E and NRASQ61R melanoma cell lines, and expressed relatively
    to the median value in all five cell lines. *p ≤ 0.05 versus median value
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - hsp-90
  - hsp-70
  - eif-2alpha
  - eif-2A
  - mek-1
  - eif-2D
  - atf-4
  - xbp-1
  - atf-6
  - mek-2
  - HSP90AA1
  - HSP90B1
  - TRAP1
  - HSP90AB1
  - TRA
  - THRA
  - TRAC
  - HSPA1A
  - HSPA4
  - HSPA5
  - KRAS
  - HRAS
  - NRAS
  - EIF2AK3
  - BRAF
  - EIF2A
  - EIF2S1
  - MAP2K1
  - EIF2D
  - ANXA2
  - NT5C3A
  - H3C9P
  - ATF4
  - MAPK3
  - MAPK1
  - XBP1
  - XBP1P1
  - DDIT3
  - BCL2L11
  - ATF6
  - CD40
  - ARHGEF7
  - ASCC1
  - H3P40
  - MAP2K2
  - KRT12
  - SECTM1
  - KCNA1
  - EPCAM
  - MAP2K7
  - Cancer
---
